A pilot study of 0.4% povidone-iodine nasal spray to eradicate SARS-CoV-2 in the nasopharynx

Rujipas Sirijatuphat, Amorn Leelarasamee, Thanapat Puangpet, Arunee Thitithanyanont
doi: https://doi.org/10.1101/2022.08.18.22278340

Article usage

Article usage: August 2022 to August 2025

AbstractFullPdf
Aug 202283511118
Sep 2022216227
Oct 2022323432
Nov 202240009
Dec 2022359124
Jan 2023142119
Feb 202359217
Mar 202396016
Apr 202394417
May 202349212
Jun 20235554
Jul 202310936
Aug 20232871110
Sep 2023301913
Oct 2023221109
Nov 2023175157
Dec 2023210510
Jan 202414225
Feb 202410419
Mar 20246105
Apr 20245959
May 20244558
Jun 20245865
Jul 20248539
Aug 202411856
Sep 202410775
Oct 20245797
Nov 202448226
Dec 2024951712
Jan 202592146
Feb 2025833013
Mar 2025673618
Apr 202564416
May 2025956118
Jun 2025413218
Jul 2025642011
Aug 2025201
Back to top
Posted August 22, 2022.
Download PDF
Data/Code
Email
A pilot study of 0.4% povidone-iodine nasal spray to eradicate SARS-CoV-2 in the nasopharynx
Rujipas Sirijatuphat, Amorn Leelarasamee, Thanapat Puangpet, Arunee Thitithanyanont
medRxiv 2022.08.18.22278340; doi: https://doi.org/10.1101/2022.08.18.22278340
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area